Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

Dec. 10, 1996

NIH offers invention for treating and diagnosing HIV infection for licensing

Dec. 4, 1996

NIH offers licenses for invention related to fusin

Dec. 4, 1996

Promising clinical results reported for C. parvum therapeutic

Dec. 4, 1996

Another European market introduction for Epivir

Nov. 28, 1996

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Purified or recombinant proteins for HIV infection available for licensing

Nov. 26, 1996

Purified or recombinant protein for HIV infection and cancer offered for licensing

Nov. 26, 1996

Anti-HIV drug now available in U.K.

Nov. 26, 1996

LeukoSite and Warner-Lambert collaborate on drugs blocking the CCR5 receptor

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...